Health Condition 1: L80- Vitiligo
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: i) All patient of either sex in the age group 15-60 years ii)Patient with body surface area involvement less than 20%
Exclusion criteria
Exclusion criteria: Before Study i) Age less than 15 years and more than 60 years ii) Body surface areainvolvement more than 20 % iii) history of photosensitivity iv) history of administration of drugs causing photosensitization v)history of any treatment of vitiligo in precceding 3 months vi)severe hepatic, renal and systemic disease vii) mucosal vitiligo During Study i) if patient develops severe side effects / intolerant during treatment ii) if patient wants to discontinue the treatment. iii) if patient uses any other medication (other than study medication and therapy) during the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| repigmentation in vitiligo lesionsTimepoint: 36 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| the efficacy and tolerability of Narrowband UVB with 0.1 % tacrolimus in treatment of vitiligoTimepoint: 1 year | — |
Countries
India
Contacts
VARUN ARJUN MEDICAL COLLEGE AND ROHILKHAND HOSPITAL , SHAHJAHANPUR, UTTAR PRADESH